Clinical characteristics and therapeutic effects of checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer

BACKGROUND: With the application of immune checkpoint inhibitors (ICIs) in cancer treatment, more and more attention has been paid to checkpoint inhibitor-related pneumonitis (CIP), which requires a better understanding of its clinical characteristics and therapeutic effects. METHODS: The clinical a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Li, Xie, Mei, Ma, Xidong, Huang, Aiben, Song, Jialin, Yao, Jie, Deng, Hui, Zhang, Duchao, Zang, Xuelei, Ren, Fangping, Gao, Jie, Wu, Chongchong, Wang, Yuanyong, Zhang, Xin, Bao, Xinyu, Pan, Lei, Xue, Xinying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983156/
https://www.ncbi.nlm.nih.gov/pubmed/36869304
http://dx.doi.org/10.1186/s12885-023-10649-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983156/
https://www.ncbi.nlm.nih.gov/pubmed/36869304
http://dx.doi.org/10.1186/s12885-023-10649-0

Ejemplares similares